Copyright independent
A new Artificial Intelligence software will be trialled in the NHS to provide men with suspected prostate cancer a diagnosis within a day. The AI technology interprets MRI scans to quickly identify high-risk lesions, prioritising them for immediate review by a radiologist. This trial, initially at up to 15 hospitals, aims to offer patients a same-day all-clear or a diagnosis within days, significantly reducing current waiting times. Health Secretary Wes Streeting and Professor Peter Johnson of NHS England hailed the technology as a potential 'game changer' for speeding up cancer diagnosis and improving patient outcomes. Developed by Lucida Medical and named Pi, the AI tool seeks to enhance the diagnostic process for prostate cancer, which affects over 58,000 men annually in England.
